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Letter to the Editor
shaping the action potential and controlling patterns ofNomenclature of Voltage-Gated
repetitive firing.Calcium Channels As new Ca21 channel genes are cloned, it is apparent
that these two alphabetical nomenclatures will overlap
at a1L, which may not mediate an L-type Ca21 current and
Voltage-gated Ca21 channels mediate calcium influx in therefore may create confusion. Moreover, the present
response to membrane depolarization and regulate in- alphabetical nomenclature does not reveal the structural
tracellular processes such as contraction, secretion, relationships among the a1 subunits, which can be
neurotransmission, and gene expression. They are mem- grouped into three families: (1) a1S, a1C, a1D, and a1F; (2)
bers of a gene superfamily of transmembrane ion chan- a1A, a1B, and a1E; and (3) a1G, a1H, and a1I. The complete
nel proteins that includes voltage-gated K1 and Na1 amino acid sequences of these a1 subunits are more
channels. The Ca21 channels that have been character- than 70% identical within a family but less than 40%
ized biochemically are complex proteins composed of identical among families. These family relationships are
four or five distinct subunits, which are encoded by illustrated for the more conserved transmembrane and
multiple genes. The a1 subunit of 190±250 kDa is the pore domains in Figure 1. Division of calcium channels
largest subunit, and it incorporates the conduction pore, into these three families is phylogenetically ancient, as
the voltage sensor and gating apparatus, and the known representatives of each are found in the C. elegans ge-
sites of channel regulation by second messengers, nome. Ideally, a nomenclature for Ca21 channel a1 sub-
drugs, and toxins. An intracellular b subunit and a trans- units should provide a systematic organization based on
membrane, disulfide-linked a2d subunit complex are their structural relationships and should be coordinated
components of most types of Ca21 channels. A g subunit with nomenclatures for the other families of voltage-
has also been found in skeletal muscle Ca21 channels, gated ion channels of different ionic selectivities (ie., K1
and related subunits are expressed in heart and brain. and Na1).
Although these auxiliary subunits modulate the proper- For these reasons, we wish to propose a new nomen-
ties of the channel complex, the pharmacological and clature of voltage-gated Ca21 channels (Table 1), which
electrophysiological diversity of Ca21 channels arises is more systematic and mimics the well-defined K1
primarily from the existence of multiple forms of a1 sub- channel nomenclature (Chandy et al., 1991). This no-
units. Mammalian a1 subunits are encoded by at least menclature uses a numerical system (KV1.1, KV2.1, KV3.1,
ten distinct genes. Historically, various names have etc.) to define families and subfamilies of K1 channels
been given to the corresponding gene products, giving based on similarities in amino acid sequences. In a simi-
rise to distinct and sometimes confusing nomencla- lar manner, we propose that Ca21 channels should be
tures. In 1994, some of us proposed a unified nomencla- renamed using the chemical symbol of the principal
ture based on the most widely accepted system at the permeating ion (Ca) with the principal physiological reg-
time: a1 subunits were referred to as a1S for the original ulator (voltage) indicated as a subscript (CaV). The nu-
skeletal muscle isoform and a1A through a1E for those merical identifier would correspond to the CaV channel
discovered subsequently (Birnbaumer et al., 1994). a1 subunit gene family (1 through 3 at present) and the
Since then, four new a1 subunits have been identified, order of discovery of the a1 subunit within that family (1
which were named a1F through a1I.
Ca21 currents recorded in different cell types have
diverse physiological and pharmacological properties,
and an alphabetical nomenclature has also evolved for
the distinct classes of Ca21 currents. L-type Ca21 cur-
rents require a strong depolarization for activation, are
long lasting, and are blocked by the organic L-type Ca21
channel antagonists, including dihydropyridines, phenyl-
alkylamines, and benzothiazepines. They are the main
Ca21 currents recorded in muscle and endocrine cells,
where they initiate contraction and secretion. N-type,
P/Q-type, and R-type Ca21 currents also require strong
depolarization for activation. They are unaffected by
L-type Ca21 antagonist drugs but are blocked by specific
polypeptide toxins from snail and spider venoms. They Figure 1. Phylogeny of Voltage-Gated Ca21 Channel a1 Subunits
are expressed primarily in neurons, where they initiate Only the membrane-spanning segments and the pore loops (z350
amino acids) are compared. First, all sequence pairs were com-neurotransmission at most fast synapses. T-type Ca21
pared, which clearly defines three families with intrafamily sequencecurrents are activated by weak depolarizations and are
identities above 80% (CaV1.m, CaV2.m, CaV3.m). Then, a consensustransient. They are resistant to both organic antagonists
sequence was defined for each family, and these three sequences
and to the snake and spider toxins used to define the were compared to one another, with interfamily sequence identities
N- and P/Q-type Ca21 currents. They are expressed in of z52% (CaV1.m versus CaV2.m) and 28% (CaV3.m versus CaV1.m
or CaV2.m).a wide variety of cell types, where they are involved in
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Table 1. Proposed Nomenclature for Cloned Voltage-Gated Ca21 Channel a1 Subunits
Gene Name and Splice Former
Name Former Names Accession Number Human Chromosome Types Names Primary Tissues
Cav1.1 a1S, a1Skm, CaCh1 X05921 CACNA1S; 1q31-32 skeletal muscle
a11.1
Cav1.2 a1C, rbC, CaCh2 CaCh2, X15539 CACNA1C; 12p13.3 Cav1.2a a1C-a heart
a11.2 Cav1.2b a1C-b smooth muscle
rbC-I, M67516; rbC-II, Cav1.2c a1C-b brain, heart, pituitary, adrenal
M67515
Cav1.3 a1D, rbD, CaCh3 M76558 CACNA1D; 3p14.3 brain, pancreas, kidney, ovary,
a11.3 cochlea
Cav1.4 a1F AJ224874 CACNA1F; Xp11.23 retina
a11.4
Cav2.1 a1A, rbA, CaCh4, BI rbA, M64373; BI-1, X57476 CACNA1A; 19p13 Cav2.1a BI1 brain, cochlea, pituitary
a12.1 BI-2, X57477 Cav2.1b BI2 brain, cochlea, pituitary
Cav2.2 a1B, rbB, CaCh5, BIII rbB, M92905; BIII, D14157; CACNA1B; 9q34 Cav2.2a a1B-1 brain, nervous system
a12.2 human a1B, M94172
Cav2.2b a1B-2 brain, nervous system
Cav2.3 a1E, rbE, CaCh6, BII rbE, L15453, BII-1, X67855; CACNA1E; 1q25-31 Cav2.3a BII brain, cochlea, retina, heart,
a12.3 human a1E, L29384 pituitary
Cav2.3b BII2 brain, cochlea, retina
Cav3.1 a1G AF027984; AF029228 CACNA1G; 17q22 Cav3.1a brain, nervous system
a13.1
Cav3.2 a1H AF051946; AF073931 CACNA1H; 16p13.3 Cav3.2a brain, heart, kidney, liver
a13.2
Cav3.3 a1I AF086827 CACNA1I; 22q12.3-13-2 Cav3.3a brain
a13.3
The cloned voltage-gated Ca21 channels and most widely studied alternate splice forms are presented together with the proposed nomenclature
and previous nomenclatures.
through m). According to this nomenclature, the CaV1 to the individual genes/proteins within the families, and
the letters x, x9, x99, and x999 identify the splice variants.family (CaV1.1 through CaV1.4) includes channels con-
taining a1S, a1C, a1D, and a1F, which mediate L-type Ca21 Standard prefixes can be placed in front of the channel
name to identify the species of origin. In this notation, thecurrents (Table 1). The CaV2 family (CaV2.1 through
CaV2.3) includes channels containing a1A, a1B, and a1E, skeletal muscle calcium channel would be written a11.1a/
b1a/g1a/a2d1a. With this new nomenclature, the CaV des-which mediate P/Q-type, N-type, and R-type Ca21 cur-
rents, respectively (Table 1). The CaV3 family (CaV3.1 ignation may also be used to identify calcium channel
auxiliary subunits such as CaVb or CaVg independent ofthrough CaV3.3) includes channels containing a1G, a1H,
and a1I, which mediate T-type Ca21 currents (Table 1). their presence in a calcium channel complex.
We hope that this new nomenclature for a1 subunits willWhen specific reference to the a1 subunit within the Ca21
channel complex is intended, the designation a11.m, be a stimulus to further research on voltage-gated Ca21
channels by providing a common, easily accessible stan-a12.m, or a13.m may be used, where the numeral m
represents the individual gene/protein within the family. dard of reference for scientists working in this field. A full-
length review article* is planned to present a more detailedWhere applicable, lowercase letters are used to distin-
guish alternatively spliced variants (e.g., CaV1.2a corre- proposal for nomenclature of the many alternate splice
forms of the a1 subunits and the auxiliary subunits ofsponds to channels containing the cardiac variant of
the former a1C). Such a systematic nomenclature has Ca21 channels that have been described in cDNA cloning
experiments.proved successful for the KV channel proteins. Its
strength resides in the rational basis derived from the
Eric A. Ertel,1 Kevin P. Campbell,2 Michael M. Harpold,3structural relationships among the channel proteins and
Franz Hofmann,4 Yasuo Mori,5 Edward Perez-Reyes,6the ease and precision with which new channels can be
Arnold Schwartz,7 Terry P. Snutch,8 Tsutomu Tanabe,9added.
Lutz Birnbaumer,10 Richard W. Tsien,11The nomenclature of the auxiliary subunits is not modi-
and William A. Catterall12,13fied, since it already includes numbers for the gene family
and lowercase letters for the splice variants. Thus, the
subunit compositions of the voltage-dependent Ca21
* This nomenclature has been approved by the Nomenclature Commit-
channels CaVn.mx may be described as a1n.mx/bm9x9/ tee of the International Union of Pharmacology, and a review article
gm99x99/a2dm999x999 complexes, where the number n de- giving more details of the nomenclature for calcium channel sub-
units and splice variants is planned for Pharmacological Reviews.fines a main family, the numbers m, m9, m99, and m999 refer
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